Enhancing metabolomic data analysis with Progressive Consensus Alignment of NMR Spectra (PCANS)
© Staab et al; licensee BioMed Central Ltd. 2010
Received: 1 May 2009
Accepted: 9 March 2010
Published: 9 March 2010
Nuclear magnetic resonance spectroscopy is one of the primary tools in metabolomics analyses, where it is used to track and quantify changes in metabolite concentrations or profiles in response to perturbation through disease, toxicants or drugs. The spectra generated through such analyses are typically confounded by noise of various types, obscuring the signals and hindering downstream statistical analysis. Such issues are becoming increasingly significant as greater numbers of large-scale systems or longitudinal studies are being performed, in which many spectra from different conditions need to be compared simultaneously.
We describe a novel approach, termed Progressive Consensus Alignment of Nmr Spectra (PCANS), for the alignment of NMR spectra. Through the progressive integration of many pairwise comparisons, this approach generates a single consensus spectrum as an output that is then used to adjust the chemical shift positions of the peaks from the original input spectra to their final aligned positions. We characterize the performance of PCANS by aligning simulated NMR spectra, which have been provided with user-defined amounts of chemical shift variation as well as inter-group differences as would be observed in control-treatment applications. Moreover, we demonstrate how our method provides better performance than either template-based alignment or binning. Finally, we further evaluate this approach in the alignment of real mouse urine spectra and demonstrate its ability to improve downstream PCA and PLS analyses.
By avoiding the use of a template or reference spectrum, PCANS allows for the creation of a consensus spectrum that enhances the signals within the spectra while maintaining sample-specific features. This approach is of greatest benefit when complex samples are being analyzed and where it is expected that there will be spectral features unique and/or strongly different between subgroups within the samples. Furthermore, this approach can be potentially applied to the alignment of any data having spectra-like properties.
Continuing technological advances are providing rich data sets quantifying an increasingly broad range of biological processes. Obvious examples include the use of microarrays for the quantification of mRNA levels and mass spectroscopy for the identification of protein states and their interactions. Coinciding with these technological developments are computational approaches for the extraction, organization and analysis of these data. The application of improved experimental methods in combination with tailored computational approaches is providing a major driving force in the development of a more global, systems perspective of biological function and disease.
Metabolomics, also referred to as metabonomics, similarly provides a comprehensive picture of biological function by focusing on quantitative measurement of metabolites in biological fluids, cells or tissues [1, 2]. The two major analytical platforms used in metabolomics are nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), the latter typically being preceded by either liquid or gas chromatography (LC/MS and GC/MS respectively). The ultimate goal of these methods is to extract accurate and quantitative information as to the identity, state and amount of detected metabolites. Increasingly common in metabolomic studies is the analysis of a large number of samples, where the resulting data is analyzed using multivariate methods such as principal components analysis (PCA). Such analyses typically require significant preprocessing of the data. In particular, it is imperative that signals for a given compound appear at the same location in all spectra. Signal locations can vary significantly, however, as in the case of LC/MS where small deviations in the chromatographic retention time can arise from variation in instrumental parameters such as flow rate, gradient slope and temperature. In NMR spectra, the peak location can vary due to differences in pH, ion content and the concentration of metabolites. For both of these methods, this variability has to be overcome in order to provide a consistent set of spectra for analysis.
The most common method of addressing variability across spectra is through binning, a procedure that involves dividing the spectra into small windows and taking the area under the curve for each window as the final intensity [3, 4]. Ideally, these windows will be large enough to encompass the peak drift, but not so large as to include many peaks in a single bin. The latter consequence is unavoidable in crowded spectra and thus there is the potential for significant loss of information when binning, for example by including peaks belonging to multiple compounds within a single bin. Alternatives to binning typically involve some form of peak alignment procedure. For LC/MS methods, a number of algorithms have been developed to align similar peaks across a set of chromatograms (e.g.  and recently reviewed in ). Similarly, several algorithms have also been recently developed to align peaks in sets of NMR spectra [7–11]. In this paper we describe a novel peak alignment method for NMR that is specifically tailored to the demands of large and disparate metabolomics datasets.
Current advanced NMR alignment methods such as fuzzy warping , Bayesian alignment , Recursive Segment-Wise Peak Alignment , peak alignment by FFT [5, 11] and peak alignment using reduced set mapping without recursive target update , are based on the use of a template spectrum to help align a set of spectra. Choosing a template typically involves either selecting a single sample spectrum that appears most like the others as determined by some measure of similarity, creating an "average" spectrum, or by choosing a reference spectrum not contained within the sample. All remaining sample spectra are then aligned to this selected template using some form of pairwise alignment algorithm. A significant problem with the template approach is that there can be a great amount of variability between any two spectra. Part of this difference arises due to the previously described chemical shift variation. In addition, significant differences arise due to the existence of disparate groups within the data; for instance, inter-group variation between control and treated groups, subpopulation differences within these groups, etc. There may often be a priori knowledge of general subgroups, but one of the goals of metabolomics is to discover new subgroups such as different types of responders in drug or toxicity studies; by definition, templates for such groups are not known beforehand. Thus in such cases, the use of a template can significantly complicate downstream analyses.
Here we describe a novel approach for the alignment of NMR spectra that is based on the creation of a consensus spectrum alignment through integration of pairwise spectrum comparisons and referred to as PCANS hereafter (Progressive Consensus Alignment of Nmr Spectra). To our knowledge, this is the first such consensus approach applied to the alignment of NMR spectra. This approach has several advantages that include the ability to align spectra with significant amounts of noise in chemical shift position, peak height and peak width. By using peaks as the basis for alignment we maintain the maximally informative set of information existing within a set of spectra. As a result, the existence of subgroups within a set of spectra can be identified since group-specific peaks are maintained in the final alignment.
We characterize the performance of this approach by aligning simulated NMR spectra which have been provided with user-defined amounts of chemical shift variation as well as inter-group differences as would be observed in control-treatment applications. Moreover, we demonstrate how our method provides better performance than either a template-based alignment or binning. Finally, we further evaluate this approach in the alignment of real mouse urine spectra and demonstrate its ability to improve downstream statistical analyses such as PCA and OPLS models commonly used in metabolomics analyses.
Results and Discussion
Alignment of simulated spectra
As "gold-standard" completely characterized NMR spectra for use in validation are not available, we used a simulation approach for generating peak profiles that could then be used to assess the performance of the alignment methods. In particular, the use of simulated profiles allows us to determine whether or not two or more peaks aligned through our algorithm should actually be aligned with each other, and if not, which other peaks they should be aligned to. It also allows us to introduce defined amounts of noise, either in the form of chemical shift variation, peak height, peak width, or randomly introduced "noise" peaks into each profile and measure their effect on alignment accuracy. As we wished to generate NMR profiles that were as realistic as possible, our simulated profiles were composed of a subset of peaks picked from an actual mouse urine spectrum (see Methods).
As a test of our alignment approach, we attempted to align simulated profiles under a variety of noise conditions. In these tests we generated two sets of profiles consisting of 32 profiles each, where each set was based on a different template. Each template consisted of a total of 50 peaks, 13 of which were unique to each group, allowing us to look at the effectiveness of alignment in the presence of inter-group variation. In addition to the differences derived from the peaks specific to each group, predefined amounts of chemical shift, peak height and peak width variation were also introduced before alignment. Finally, 50% of the profiles in each group had from 1 to 4 additional noise peaks inserted at random positions within each profile.
The effects of chemical shift variation on alignment accuracy are shown in Figure 3 where, in addition to chemical shift variation, 25% of peaks were subject to noise of ± 10% in peak height and/or peak width at half-height. The contribution of chemical shift, peak height and width to the alignment score were kept equal in this and all other tests as this combination was found to be highly robust. Sensitivity to the choice of these weighting parameters is shown in Additional File 1: Figure S2. In Figure 3 we see that the accuracy of alignment is highly robust to chemical shift variation as can be seen by the slow decrease in accuracy with increasing variation. Here, alignment accuracy is calculated by dividing the number of peaks correctly aligned by the total number of peaks. Alignment is similarly robust to increases in the proportion of peaks subjected to such variation. In fact, a nearly 90% accuracy is maintained despite 50% of peaks experiencing variation of up to ± 0.04 ppm. The maximum standard deviation is ± 0.033 and the corresponding map of deviations is shown in Additional File 1: Figure S1. While we used a window of ± 0.04 ppm in the alignment of individual peaks, this is a user-defined quantity that can be changed to suit the underlying data.
We iteratively chose one of the sixty-four peak profiles as the template to which all the other profiles were aligned. Thus this approach differs from the PCANS alignment method only in the fact that it uses a representative profile as a template for use in aligning the other peak profiles; all other steps are identical including the dynamic programming alignment of peaks. Over all 64 possible templates, the average accuracy using this approach was 84.4% with 99% confidence intervals of 84.02% and 84.68%. The best single template had an accuracy of 87.5%. In contrast, PCANS had a 93.9% accuracy (PCANS generates only one answer so there are no error bars in this case).
In Region 2 of the template alignment, we see a well-aligned peak for Group 1. However, as we are using simulated data, we know that the position of this alignment is centered at a nearby noise peak within the template profile and inspection of the unaligned profiles also shows no obvious peak. The correct result is shown in Region 2 of the PCANS alignment. This incorrect alignment occurs because the "best" template happens to contain a nearby noise peak that is used as the basis for alignment of all other profiles.
Finally, in Region 3 (unaligned) we see strong indications of a peak in Group 1 as well as alignment of this peak with PCANS. However, in the template alignment we see no obvious change relative to the unaligned profiles. This is due to the fact that the template profile had no peaks in this region and thus none of the identified peaks could be aligned. The fact that they are present at all in the final alignment is due to the PCANS-portion of the algorithm (non-template), which allows these orphan peaks to pass through to the final alignment regardless of whether or not they are found in the template. Overall, this example demonstrates the inherent pitfalls and challenges that arise with any alignment method that is based on the concept of a template or standard spectrum.
PCA analysis of simulated spectra
Similarly, Figure 5C shows the PCA scores plot of the unaligned peak profiles. In this case the four clusters do not distinguish the groups, and are again based upon differences in the peak positions of two large creatinine peaks. As with the binning example, removal of these two peaks leads to a clearer discrimination of the groups, but again with a diffuse clustering as observed in Figure 5D.
In contrast, Figure 5E shows the results of PCA analysis after alignment with PCANS. The separation between the groups along the first principal component is complete and the clustering is very tight. The outliers from each group near the top of the plot are again due to one creatinine peak that did not get aligned with the rest. Removal of this peak from the analysis lead to the scores plot in Figure 5F. Although there are still a small number of outliers, the separation between the groups along the 1st principal component is excellent and this PC explains nearly fifty percent of the variance in the data.
The final comparison is with the template aligned peak profiles. Figure 5G displays a very good discrimination of the groups, with the control groups being very tightly clustered. This is reasonable as the template was chosen from that group. If, as with the other plots, the creatine and creatinine peaks are removed, the separation looks quite similar but the percent variation explained by the first principal component decreases by nearly half. Compared with the PCANS plot, the control group is more tightly clustered, but the treated group is less well so. Furthermore, the first principal component of the PCANS alignment explains 46.5% as opposed to 35.6% of the variation. In this rather simple example of only two groups, the PCANS alignment does have some advantages, but the benefits would be expected to be much greater in a more complex situation which has more than two groups.
Alignment of Mouse Urine Spectra
Given the similarity between the binned and aligned data, the advantage of alignment with PCANS may not be obvious. However, it should be emphasized that the information content of the PCANS-aligned data is over three-fold larger than that of the binned data. More specifically, the intensity of 483 individual peaks is represented in the PCANS-aligned data, while the binned data encodes only 152 variables, many of which are influenced by (i.e. containing) multiple peaks. We can better observe the advantage that PCANS alignment provides through this added information by looking at the results of a supervised OPLS analysis.
In contrast, Figure 7D shows the loadings coefficients after PCANS alignment. As can be seen along the x-axis, data density (and thus information content), is significantly higher than with binned data. In addition, the signals from ethanol and ethylglucuronide are all very strong with colors indicating a very high confidence. Also note that while template alignment would perhaps perform similarly with regard to generating strong correlations for aligned peaks, it suffers from the earlier described difficulties that will lead to loss of peaks defining group/inter-group differences, loss of unique peaks, and alignment of different, but close peaks to nearby peaks within the template. These results demonstrate the value alignment with PCANS and its ability to enhance the information content relative to the standard binning protocol.
The increasing scale and complexity of metabolomics studies is driving the need for improved computational tools for data integration and analysis. We have described our PCANS approach which was developed to address the need for multiple spectrum alignment where noise in the form of chemical shift variation and deviations in peak properties is present, along with significant sample complexity.
In metabolomic analyses there are often multiple groups of spectra, such as control and treated groups, which may not be appropriately aligned with any algorithm that is primarily based upon the use of a template. For instance, the peaks from the exogenous metabolites that are present in the treated group may not be well aligned using a template from the control group. Similarly, alignment of the control spectra could be confounded by the presence of the exogenous peaks in the template. Even when a specific group (e.g. the treatment group) can be reasonably well aligned by a representative template spectrum, metabolomics is also being increasingly used to determine multiple responder phenotypes wherein the treated group may contain several subgroups characterized by distinctly different spectra. Thus a significant advantage of PCANS over the use of template-derived methods is that it is a fully unsupervised method and can be used to align spectral data containing multiple disparate groups that may not/cannot be anticipated. Furthermore, as both aligned and unaligned peaks are incorporated into the final consensus, we minimize the amount of data lost in this process while enhancing the signal within alignable regions.
This algorithm uses peaks rather than full resolution spectra as the basis for alignment. We consider this to be a general advantage as the datasets are much smaller while having no loss of real spectral information, as peak location, height and width are all maintained. A primary goal of the PCANS process is to provide better input data for multivariate statistical analysis that will help identify significant groups in the sample set. As shown in the OPLS loadings coefficients plots in figure 7, the peak profiles provide an ample representation of the NMR spectra so that specific compounds can be identified. It could be argued that these peak profiles are even easier to interpret than real spectra as they are free from spectral noise and have perfectly uniform linewidths. But, should a more traditional representation of NMR spectra be desired, the information has been maintained to regenerate such a spectrum. In general, the use of peak profiles as input to PCANS allows us to maximize the amount of high-quality information available for alignment and further downstream analysis. We are further investigating the use of more sophisticated peak picking algorithms that will include recognition of peak multiplets and advanced recognition of shoulder peaks that are often present in samples such as serum that displays large, broad peaks due to the presence of macromolecules. While we have used a robust peak picking algorithm, improvements in this step will help minimize issues of inconsistent peak selections across samples. Continued incorporation of more sophisticated scoring schemes as well as more realistic handling of multiplets (rather than as separate peaks), is expected to further enhance the effectiveness of our approach. Finally, while PCANS was developed specifically with NMR data in mind, it has the potential to be applicable to the alignment of other types of data with similar properties. In particular, chromatographic data which is composed of peak positioned along a time axis would be amenable to PCANS alignment. Future work will attempt to further extend these capabilities.
Experimental NMR data collection and processing
Complete details on the urine collection and sample preparation are given in . Briefly, the samples consisted of 540 ml of urine plus 60 ml of a D2O solution containing 5 mM trimethylsilylpropionate-d4 (TSP) as a concentration and chemical shift reference. The solutions were transferred to 5 mm NMR tubes and NMR spectra were acquired on a Varian Inova 400 MHz spectrometer using a 5 mm pulsed field gradient, inverse detection probe (Varian, Inc., Palo Alto, CA). The spectra were acquired with 1024 transients and a sweep width of 4650 Hz digitized with 16384 points. The pulse sequence included a 4 second solvent presaturation period and a 2.6 second acquisition time. A 45 degree excitation pulse was used to provide quantitative results.
The data were processed using ACD software version 9 (Advanced Chemistry Development, Toronto, Canada). A 0.1 Hz exponential line broadening was applied to the data. The spectra were phased and baseline corrected using a 6th order polynomial fitting algorithm implemented in the software. The spectra were normalized to the integral for the TSP peak. The digitized spectra were exported as text files for subsequent peak picking prior to alignment with the PCANS method. Spectral binning was carried out by dividing the spectrum into uniform 0.04 ppm bin windows and taking the integral value as the sum of the intensities of all peaks in that bin. The regions from 0.5 to 4.7 ppm and 4.9 to 9.5 were included in the integration. The regions below 0.5 and above 9.5 contained only noise and the region from 4.7 to 4.9 contained the residual solvent peak.
Multivariate statistical analysis
The statistical analyses were performed using SimcaP+ version 11.5 (Umetrics, Umea, Sweden). Pareto scaling was applied to both the peak picked and binned NMR data prior to principal component analysis (PCA) and orthogonal projection to latent structures - discriminant analysis (OPLS-DA) [13, 14].
The simulated spectra were based upon peaks manually chosen from an actual urine spectrum. Peaks were chosen such that they contained a range of features typically found within normal spectra including tall and small peaks, clusters of many closely spaced peaks, doublets, etc. These peaks and their associated chemical shift position, height and width were then used as the basic material from which simulated spectra (peak profiles) were generated. Thus, the peaks used for simulation are a representative subset of the original spectrum and the simulation program uses sets of these along with defined amounts and types of variation to generate the simulated profiles. For simulated spectra, the steps responsible for peak detection and peak attribute assignment are skipped since the simulated spectra are already defined with a set of peaks with associated attributes.
For real NMR spectra, the peak detection algorithm uses the derivative of the spectrum to detect and define potential peaks. Potential peaks must have a zero first derivative, a negative second derivative and be composed of at least 8 points, where points here refer to data values from the digitized raw spectra. In addition, we use the number of points that define a peak as well as peak height relative to neighbors to determine 'real' peaks from noise peaks within a given spectrum. Specifically, for each potential peak, we look in a region centered around this point (151 points in this work) and call this a 'true' peak if it exceeds a user defined height. This threshold height is based on the height of surrounding points within this region. In this work a true peak had to have a height greater than 70% of the surrounding points. The resulting peaks that define each spectrum are characterized by the attributes of relative intensity (height) at peak apex, chemical shift position at peak apex, and the width at half-height of the peak. The width at half-height is calculated by fitting a triangle to the peak based on the points prior and immediately after the apex point. The base of the triangle estimates the width at half height for the peak. Note that if peaks are not perfect Lorentzians, then relative intensity and width at half-height will not be redundant information.
The PCANS algorithm
The overall flow of the PCANS alignment algorithm is diagrammed in Figure 1. Detailed algorithm pseudocode for both naive and dynamic programming alignment is provided in Additional File 2. After peak detection, the remaining alignment steps are the same for both real and simulated spectra. The process begins with highly similar pairs of spectra being identified using synchronous sample-sample correlation (Figure 1A) . We note that the statistical correlation between spectra will be more influenced by the larger peaks, but this is simply a starting point in choosing which spectra to try and align first into a consensus spectrum; all peaks will ultimately be aligned. Once the alignment pairs have been identified, the pairwise alignment process begins with naive peak alignment as illustrated in Figure 1B. The naive peak alignment algorithm aligns corresponding peaks within the pair that have ninety percent or greater similarity across all peak attributes. Doing so also generates unaligned regions that are often bounded on both sides by regions composed solely of these highly similar (and easily alignable) peaks.
In both the naive as well as dynamic programing alignment, described next, crossover of peaks is prevented. Here, crossover is defined as shifting a peak over an adjacent peak that has already been aligned to a peak in the paired peak profile. In addition, peaks are restricted by the amount of chemical shift position movement that is allowed based upon a user defined maximum. Therefore, a pair of peaks will only align together if the amount of movement that the peaks need to make for the alignment is less than this user defined maximum. Typically, the user would define this maximum chemical shift position movement as ± 0.04 or ± 0.03 ppm, but the value is data dependent. We note that by aligning each peak within its own user defined window the notion of linear or non-linear shifting of peaks across the spectrum need not be considered.
The next step in alignment involves defining corresponding unaligned segments of the peak profile pair as depicted in panel C of Figure 1. Here, each spectra is segmented such that only the unaligned peaks contained within a segment will be subject to the dynamic programming alignment process. Again, these segments are paired between the two peak profiles and segments are bounded on each side either by already aligned regions or "empty" regions where it is impossible to form an alignment between a pair of peaks based upon the user-defined maximum chemical shift variation.
A modified dynamic programming algorithm is used to align peaks within each of the segments (see Additional File 2 for pseudocode). The algorithm involves using the typical dynamic programming recursion, where the scores assigned for a given alignment between peaks are defined using the scoring function enumerated above with a gap penalty, gp, is imposed for unaligned peaks. The modification involves assigning a large penalty, the boundary penalty bp, when alignment between two peaks involves chemical shift variation greater than m or when two aligned peaks do not achieve the minimum acceptable similarity for alignment, minScr. The user defines both of these values, -0.10 gp and -5.0 bp in this work, with the assignment of the large penalty preventing the algorithm from violating either the maximum allowable chemical shift variation, m, or the minimum allowable similarity for alignment.
Panel E of Figure 1 illustrates the final step in the process where the consensus peak profile is formed. Specifically, the consensus profile is generated by assigning a new consensus peak to each successfully aligned pair of peaks, where this consensus peak takes on the median chemical shift value and the average relative height and width of the paired aligned peaks. Peaks from either profile that fail to align are allowed to "pass-through" to the consensus profile and maintain their original attributes. Panel E of Figure 1 depicts successfully aligned peaks as those contained within a shaded box, those that failed alignment are unadorned.
Figure 2 illustrates how the entire process diagrammed in Figure 1 is repeated on the resulting consensus profiles until a single consensus profile is produced. The peak profiles in the top row of figure 2 demonstrate the initial step where the pairs of input profiles are aligned together to form consensus profiles. The next steps involve pairing these resulting consensus profiles together, aligning them and forming 'new' consensus profiles. This process is repeated until only a single consensus profile exists as depicted at the bottom of Figure 2. This final consensus profile is used to adjust the chemical shift positions of the peaks from the original input profiles to their final aligned positions.
For the determination of optimal alignment parameters (p h , p w and p c in the scoring function), we perturbed the peak attributes of the simulated peak profiles in a variety of different ways. Additional File 1: Figure S2 depicts a representative result of one of the many simulations that were run. The results from these experiments indicate that using equal proportions is robust regardless of the perturbations introduced, as long as all three attributes experienced some amount of perturbation. If the amount of perturbation experienced by one of the three attributes is expected to be considerably less than the other two, the user might consider increasing its contribution to the score function.
In our Python implementation, alignment of the described 22 real mouse urine spectra takes approximately 2 minutes on a 2 GHz laptop. Approximately 30 seconds involves the actual process of alignment, with the remaining time involving peak picking and other data processing. Alignment of 150 real mouse urine spectra takes approximately 38 minutes with 1 min 54 sec being involved in alignment.
Simulation of NMR spectra peak profiles
To generate NMR profiles that were as realistic as possible our simulated peak profiles are based upon characteristics of urine spectra from mice. Specifically, we follow the distribution of peak locations, heights and widths as estimated from murine urine spectra using the spectrum visualization utility implemented in ACD 1D NMR Processor, version 11 (Advanced Chemistry Development, Toronto, Canada). The spectral peaks used for calculating these distributions range in chemical shift position from 2.0 ppm to 4.10 ppm. These distributions are coded into a software utility that allows the generation of simulated peak profiles. In addition, user-defined levels of noise in chemical shift position, height and width can be defined. To help simulate attributes observed with real NMR spectra, the number of peaks generated per spectrum is varied through the addition of noise peaks to the simulated profiles. To evaluate algorithm performance with profiles originating from multiple distinct classes, we generate spectra from distinctly different templates where the user defines the number of peaks common between templates.
Availability of the software
Financial support for these studies was provided, in part, by the United States Environmental Protection Agency grant (RD833825). However, the research described in this article has not been subjected to the Agency's peer review and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. This research was also supported by a grant from the National Institute of Environmental Health Sciences (P30ES10126).
- Nicholson JK, Lindon JC, Holmes E: Metabonomics: Understanding the Metabolic Responses of Living Systems to Pathophysiological Stimuli via Multivariate Statistical Analysis of Biological NMR Spectroscopic Data. Xenobiotica 1999.
- Robertson DG: Metabonomics in Toxicology: A Review. Toxicological Sciences 2005.
- Gartland K, Beddell C, Lindon J, Nicholson J: Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol 1991, 39(5):629–642.PubMed
- Anthony M, Sweatman B, Beddell C, Lindon J, Nicholson J: Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol Pharmacol 1994, 46: 199–211.PubMed
- Wong JWH, Durante C, Cartwright HM: Application of Fast Fourier Transform Cross-Correlation for the Alignment of Large Chromatographic and Spectral Datasets. Analytical Chemistry 2005, 77(17):5655–5661. 10.1021/ac050619pView ArticlePubMed
- America AHP, Cordewener JHG: Comparative LC-MS: A landscape of peaks and valleys. Proteomics 2008, 8(4):731–749. 10.1002/pmic.200700694View ArticlePubMed
- Wu W, Daszykowski M, Walczak B, Sweatman BC, Connor SC, Haselden JN, Crowther DJ, Gill RW, Lutz MW: Peak Alignment of Urine NMR Spectra Using Fuzzy Warping. Journal of Chemical Information and Modeling 2006, 46(2):863–875. 10.1021/ci050316wView ArticlePubMed
- Kim S, Wang Z, Duran CM: A Bayesian Approach for the Alignment of High-Resolution NMR spectra. Proceedings of the INFORMS Artificial Intelligence and Data Mining Workshop, Pittsburgh, PA, USA 2006, 1–6.
- Torgrip RJO, Åberg KM, Karlberg B, Jacobsson SP: Peak alignment using reduced set mapping. Journal of Chemometrics 2003, 17(11):573–582. 10.1002/cem.824View Article
- Veselkov KA, Lindon JC, Ebbels TMD, Crockford D, Volynkin VV, Holmes E, Davies DB, Nicholson JK: Recursive Segment-Wise Peak Alignment of Biological 1H NMR Spectra for Improved Metabolic Biomarker Recovery. Analytical Chemistry 2009, 81: 56–66. 10.1021/ac8011544View ArticlePubMed
- Savorani F, Tomasi G, Engelsen S: icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. Journal of Magnetic Resonance 2010, 202(2):190–202. 10.1016/j.jmr.2009.11.012View ArticlePubMed
- Bradford BU, O'Connell TM, Han J, Kosyk O, Shymonyak S, Ross PK, Winnike J, Kono H, Rusyn I: Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicology and Applied Pharmacology 2008, 232(2):236–243. 10.1016/j.taap.2008.06.022View ArticlePubMedPubMed Central
- Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, Hudson J, Blancher C, Gauguier D, Lindon JC, Holmes E, Nicholson J: Statistical Total Correlation Spectroscopy: An Exploratory Approach for Latent Biomarker Identification from Metabolic 1H NMR Data Sets. Analytical Chemistry 2005, 77(5):1282–1289. 10.1021/ac048630xView ArticlePubMed
- Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz J, Trygg J: Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models. Analytical Chemistry 2008, 80: 115–122. 10.1021/ac0713510View ArticlePubMed
- Sasic S, Muszynski A, Ozaki Y: A New Possibility of the Generalized Two-Dimensional Correlation Spectroscopy. 1. Sample-Sample Correlation Spectroscopy. Journal of Physical Chemistry A 2000, 104(27):6380–6387. 10.1021/jp000510fView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.